Stock Track | BIOCYTOGEN-B Soars 5.12% Intraday on Strategic Collaboration for Weight Loss Drug Development

Stock Track04-02

BIOCYTOGEN-B's stock price soared 5.12% during the intraday session on Thursday, following the announcement of a significant strategic partnership.

The surge is attributed to the company entering into a strategic collaboration with SIHUAN PHARM to accelerate the research and development of innovative drugs in high-potential areas, including weight loss. The partnership will leverage Biocytogen's AI-driven fully human antibody R&D platform combined with Sihuan's expertise in drug development and commercialization.

This collaboration aims to establish a long-term relationship to advance the development and commercialization of cutting-edge global therapies, which has positively influenced investor sentiment towards BIOCYTOGEN-B's future growth prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114582605?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 10:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114582605","market":"nz","top_or_hot":-1,"title":"Stock Track | BIOCYTOGEN-B Soars 5.12% Intraday on Strategic Collaboration for Weight Loss Drug Development","media":"Stock Track","content":"<p>BIOCYTOGEN-B's stock price soared 5.12% during the intraday session on Thursday, following the announcement of a significant strategic partnership.</p><p>The surge is attributed to the company entering into a strategic collaboration with SIHUAN PHARM to accelerate the research and development of innovative drugs in high-potential areas, including weight loss. The partnership will leverage Biocytogen's AI-driven fully human antibody R&D platform combined with Sihuan's expertise in drug development and commercialization.</p><p>This collaboration aims to establish a long-term relationship to advance the development and commercialization of cutting-edge global therapies, which has positively influenced investor sentiment towards BIOCYTOGEN-B's future growth prospects.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BIOCYTOGEN-B Soars 5.12% Intraday on Strategic Collaboration for Weight Loss Drug Development</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BIOCYTOGEN-B Soars 5.12% Intraday on Strategic Collaboration for Weight Loss Drug Development\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-02 10:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BIOCYTOGEN-B's stock price soared 5.12% during the intraday session on Thursday, following the announcement of a significant strategic partnership.</p><p>The surge is attributed to the company entering into a strategic collaboration with SIHUAN PHARM to accelerate the research and development of innovative drugs in high-potential areas, including weight loss. The partnership will leverage Biocytogen's AI-driven fully human antibody R&D platform combined with Sihuan's expertise in drug development and commercialization.</p><p>This collaboration aims to establish a long-term relationship to advance the development and commercialization of cutting-edge global therapies, which has positively influenced investor sentiment towards BIOCYTOGEN-B's future growth prospects.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02315","symbol_name":"百奥赛图-B","start_time":0,"source_url":"","article_id":"1114582605","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114582605","pubTimestamp":1775098276,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BIOCYTOGEN-B's stock price soared 5.12% during the intraday session on Thursday, following the announcement of a significant strategic partnership.The surge is attributed to the company entering into...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02315":"百奥赛图-B"},"translate_title":"个股追踪|百奥赛图-B盘中大涨5.12%因减肥药开发战略合作","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02315":1},"content_text":"BIOCYTOGEN-B's stock price soared 5.12% during the intraday session on Thursday, following the announcement of a significant strategic partnership.The surge is attributed to the company entering into a strategic collaboration with SIHUAN PHARM to accelerate the research and development of innovative drugs in high-potential areas, including weight loss. The partnership will leverage Biocytogen's AI-driven fully human antibody R&D platform combined with Sihuan's expertise in drug development and commercialization.This collaboration aims to establish a long-term relationship to advance the development and commercialization of cutting-edge global therapies, which has positively influenced investor sentiment towards BIOCYTOGEN-B's future growth prospects.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114582605","isCrawlerRequest":true}